Marketing

Brukinsa Clarity ad
Favicon Fierce Pharma

BeOne TV drug ad hit by FDA over ‘misleading suggestions’

The FDA has issued an untitled letter to BeOne Medicines’ U.S. subsidiary over a TV commercial promoting its BTK blood cancer drug Brukinsa.
Ben Adams May 13, 2026 11:11am
whale jumping out of water
Favicon Fierce Pharma

Orca rides $250M funding wave toward cancer cell therapy launch

Jan 9, 2026 11:19am
change direction new plan alter arrows move reprioritize
Favicon Fierce Pharma

Cybin alters state to become Helus Pharma for Nasdaq trip

Dec 19, 2025 10:30am
New CEO executive boardroom leader
Favicon Fierce Pharma

Amgen obesity marketing head Boulton departs to lead Prolynx

Dec 11, 2025 10:40am
Boerner
Favicon Fierce Pharma

BMS touts commercial execution, reckons with clinical setbacks

Jul 31, 2025 11:10am
Graphic of a fork in the road with arrows pointing in either direction
Favicon Fierce Pharma

Prasad exit signals more permissive FDA for cell and gene field

Jul 31, 2025 9:10am